Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Wed, 13.07.2022       Deutsche Rohstoff AG

First Berlin Equity Research hat ein Research Update zu Deutsche Rohstoff AG (ISIN: DE000A0XYG76) veröffentlicht. Analyst Simon Scholes bestätigt seine BUY-Empfehlung und senkt das Kursziel von EUR 43,00 auf EUR 36,00. Zusammenfassung: Die vorläufigen Ergebnisse für Q2/22 zeigen einen Anstieg des EBITDAs um 83,4 % auf €3 [ … ]
Wed, 13.07.2022       Advanced Blockchain AG

The Gateway to DeFi, Crypto & Web 3.0. Significant upside potential due to the well diversified portfolio. Successful partial divestments and financing rounds confirm the Group's investment approach. Advanced blockchain AG is a blockchain venture builder focused on investing, developing, and scaling in disruptive technologies including token [ … ]
Wed, 13.07.2022       Advanced Blockchain AG

The Gateway to DeFi, Crypto & Web 3.0. Significant upside potential due to the well diversified portfolio. Successful partial divestments and financing rounds confirm the Group's investment approach. Advanced blockchain AG is a blockchain venture builder focused on investing, developing, and scaling in disruptive technologies including token [ … ]
Wed, 13.07.2022       MagForce AG

- Stage 2b of the trial for approval in the USA is currently ongoing - Billing code by the American Medical Association is available - Break-even expected from 2024 In the past financial year 2021, MagForce AG continued or resumed the planned European roll-out for the treatment of malignant brain tumours (glioblastoma). The four NanoActivator de [ … ]
Wed, 13.07.2022       MagForce AG

- Stage 2b of the trial for approval in the USA is currently ongoing - Billing code by the American Medical Association is available - Break-even expected from 2024 In the past financial year 2021, MagForce AG continued or resumed the planned European roll-out for the treatment of malignant brain tumours (glioblastoma). The four NanoActivator de [ … ]
Wed, 13.07.2022       wallstreet:online AG

13/07/2022 - Management interview with wallstreet:online AG 'We see ourselves as a next generation broker and disruptor of the classic broker market in Germany. The transaction business will account for the largest share of our revenues in a few years. ' wallstreet:online AG (wallstreet:online) operates Smartbroker - a multiaward -winning onli [ … ]
Wed, 13.07.2022       wallstreet:online AG

13/07/2022 - Management interview with wallstreet:online AG 'We see ourselves as a next generation broker and disruptor of the classic broker market in Germany. The transaction business will account for the largest share of our revenues in a few years. ' wallstreet:online AG (wallstreet:online) operates Smartbroker - a multiaward -winning onli [ … ]
Tue, 12.07.2022       Advanced Blockchain AG

Advanced Blockchain AG, is an agile venture builder and investor in the blockchain ecosystem. The company is equipped with a comprehensive team of developers, researchers, auditors, economists, and mathematicians that are dedicated to engineering the future of our internet - termed 'Web3'. The company announced important strategic adjustments to [ … ]
Tue, 12.07.2022       Advanced Blockchain AG

Advanced Blockchain AG, is an agile venture builder and investor in the blockchain ecosystem. The company is equipped with a comprehensive team of developers, researchers, auditors, economists, and mathematicians that are dedicated to engineering the future of our internet - termed 'Web3'. The company announced important strategic adjustments to [ … ]
Mon, 11.07.2022       Formycon AG

First Berlin Equity Research hat ein Research Update zu Formycon AG (ISIN: DE000A1EWVY8) veröffentlicht. Analyst Simon Scholes bestätigt seine BUY-Empfehlung und erhöht das Kursziel von EUR 89,00 auf EUR 97,00. Zusammenfassung: Die britische Aufsichtsbehörde genehmigte das Lucentis-Biosimilar FYB201 von Formycon im Mai, und d [ … ]

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
About the newsfeed
#1
Where does the information come from?

The information is provided as part of a content partnership by one of Europe's leading news data providers, the Munich-based EQS Group.

#2
Will editorial changes be made?
The portal site is part of the EQS-Newswire distribution network. The information is provided 'as is'. No editorial adjustments are made. The detailed views are enriched with additional information in order to offer interested investors further research options.
#3
From which news source does the information originate?
As a rule, it is the companies themselves that provide information, either through their own public relations work or via partner agencies. Due to the wide reach of the EQS distribution network and the associated multiplier effects, this service is often used to reach interested parties quickly and in a targeted manner. The EQS Group counts almost all listed companies among its customers.
#4
Are the messages provided in real time?

The data feeds are updated at regular intervals. You can obtain the latest information directly from EQS if required. Simply follow the link below.

#5
Are there plans to expand the scope of the news?

If investor-relevant topics are involved, it is possible to connect additional data providers. In Q1/2024, mwb Research was added to the information offering in the rating area.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Monday, 12.05.2025, Calendar Week 20, 132nd day of the year, 233 days remaining until EoY.